CALEB LUSK: Open Payments
NPI 1386149912 · SAN PEDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 47 payments from 12 companies in 2025. Trend: 2023 $4,997 · 2024 $920 · 2025 $1,371
Food & beverage: $1,371
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $544 |
| ABBVIE INC. | 12 | $287 |
| ViiV Healthcare Company | 4 | $131 |
| Amgen Inc. | 3 | $65 |
| Novo Nordisk Inc | 3 | $61 |
| Indivior Inc. | 2 | $59 |
| Braeburn Inc. | 2 | $55 |
| Exact Sciences Corporation | 2 | $47 |
| Lilly USA, LLC | 2 | $46 |
| Sage Therapeutics, LLC | 1 | $25 |
Products named: MAVYRET, Epclusa, APRETUDE, VRAYLAR, OTEZLA, SUBLOCADE, BRIXADI, Wegovy.
Industry payments across CA — which companies pay providers there.
